Low Libido

By Sophora Health Editorial Team  ·  Medically reviewed  ·  Published July 2026  ·  Last reviewed July 2026

Desire used to arrive on its own. You did not have to think about it, plan for it, or wonder where it had gone. Now it feels distant, like something that belongs to a version of you from a few years ago.

It is not that you have stopped caring about intimacy. It is that the spark that used to start things has quietened. You are left wondering whether this is permanent, whether it is you, or whether something specific is happening.

Something specific is happening. Up to 40 to 50 percent of women experience a meaningful decline in sexual desire during perimenopause and menopause. It is driven by a measurable hormonal shift, primarily involving testosterone, alongside estrogen decline and several compounding factors.

Understanding the mechanism is the first step toward addressing it. Low libido in perimenopause is one of the more treatable symptoms of this transition once it is named correctly, because different components respond to different interventions.

Someone important to you needs this too.

WhatsAppiMessageCopy LinkEmail

Why desire changes: the testosterone mechanism

Testosterone is often discussed as a male hormone, but women produce it too, from the ovaries and adrenal glands throughout life. It plays a central role in sexual desire and arousal.

Testosterone levels begin declining gradually from a woman’s 30s and continue dropping through perimenopause, reaching roughly half of peak levels by the time of menopause.

This decline is a natural result of ageing, not menopause itself. Its effects on desire become more noticeable in perimenopause as estrogen and progesterone also fall.

Estrogen decline compounds this in a separate way. Falling estrogen contributes to vaginal dryness and thinning of the vaginal lining, making penetrative sex physically uncomfortable. This understandably reduces desire for an activity now linked to discomfort.

Estrogen decline is also linked to reduced blood flow to genital tissue, which affects physical arousal separately from psychological desire. Poor sleep from night sweats and hormonal insomnia reduces general interest in sex simply through exhaustion.

And perimenopausal mood changes, including higher rates of depression and anxiety during this transition, independently reduce sexual desire through entirely separate neurological pathways.

Desire, arousal, and pain are distinct components of sexual function, and low libido in perimenopause often involves more than one simultaneously.

The Menopause Society identifies these as overlapping but separate problems: reduced desire, reduced arousal from blood flow changes, and pain from vaginal tissue changes. Identifying which of these is driving your specific experience changes what treatment is most likely to help.

Someone important to you needs this too.

WhatsAppiMessageCopy LinkEmail

What actually helps

Address the physical discomfort first

If pain during sex is part of the picture, treating vaginal dryness through moisturisers, lubricants, or local vaginal estrogen often improves desire indirectly.

It is difficult to want an activity that has become physically uncomfortable, and removing that barrier frequently allows underlying desire to resurface on its own. This is worth addressing before assuming the issue is purely psychological or hormonal at the desire level.

Testosterone therapy

Evidence supports testosterone therapy for low sexual desire in both perimenopausal and postmenopausal women. A testosterone patch or gel, applied transdermally, has shown noticeable increases in sexual desire across multiple studies.

No testosterone product is currently FDA-approved specifically for women in the United States. Use is off-label, typically a compounded formulation prescribed and monitored by an experienced doctor.

Potential side effects include acne and unwanted hair growth, and long-term safety data is still being gathered. This is a conversation for a doctor who monitors it properly, not a self-directed approach.

Estrogen therapy: route matters

Research on estrogen and libido has produced a useful finding. When estrogen was given via pill or skin patch, both improved vaginal dryness and pain, but only the patch was linked to increased libido.

This suggests that route of delivery affects outcomes beyond the general symptom relief that any effective HRT provides. This is a specific detail worth raising directly if libido is a primary concern in the HRT conversation.

Address the sleep and mood layer

Sleep disruption and mood changes independently reduce desire. Addressing them removes contributing factors that compound the hormonal picture.

Desire has a psychological component that is genuinely affected by exhaustion and low mood, separate from the hormonal mechanism. Treating one without the other often produces incomplete results.

Non-hormonal medication options

Flibanserin, taken daily, and bremelanotide, self-administered before sexual activity, are both FDA-approved non-hormonal medications for low sexual desire, though currently approved specifically for premenopausal women. They work through different neurological pathways, adjusting the balance of neurotransmitters including serotonin and dopamine involved in desire.

Whether and how these apply to perimenopausal women is a conversation worth having directly with a doctor, as off-label use and emerging evidence continue to develop.

Rebuilding the psychological and relational layer

Desire is not purely mechanical. Body image changes, relationship dynamics, communication about changing needs, and giving yourself permission to explore what feels good now all play a genuine role.

Individual or couples therapy focused specifically on sexual health can help work through the layers that are not purely hormonal. This is not a substitute for addressing the physical and hormonal mechanisms, but it matters alongside them.

“Desire did not disappear. The hormonal signal that used to generate it automatically has quietened, and that is a specific, addressable problem, not a permanent state.”

When to see a doctor

Make an appointment if the change in desire is causing you distress, affecting your relationship, or if you want to explore testosterone or other treatment options. This is worth raising even if you feel uncertain about how to describe it. Use Sophora’s The Answers You Need to describe your specific experience, whether desire, arousal, pain, or a combination, so the conversation targets the right treatment.

Questions you are probably asking

Is low libido a normal part of perimenopause?

Yes, very common, affecting up to half of women during this transition. It is driven primarily by declining testosterone, compounded by estrogen-related vaginal changes, sleep disruption, and mood changes. Common does not mean it has to be accepted without addressing it.

Multiple evidence-based treatments exist, and identifying which specific component, desire, arousal, or pain, is most affected helps target treatment effectively.

Will my libido come back after menopause?

For some women, desire stabilises once hormone levels settle at a consistent postmenopausal baseline. For others, particularly where testosterone has declined significantly, low libido persists without active treatment.

This is genuinely individual, which is why identifying the specific mechanisms driving your experience, rather than waiting to see what happens, gives you more control over the outcome.

Can testosterone therapy help even though I am not a man?

Yes. Testosterone is produced naturally by women throughout life and plays a genuine role in female sexual desire. Evidence supports transdermal testosterone therapy for low sexual desire in perimenopausal and postmenopausal women specifically.

It requires medical supervision because dosing needs to stay within physiological female ranges to avoid side effects. No product is currently FDA-approved for this use, so it is prescribed off-label by experienced doctors.

Is my low libido about hormones or about something else?

It is very often both, which is why a single explanation rarely captures the full picture. Hormonal decline, particularly in testosterone, is the most common physiological driver.

But relationship dynamics, stress, body image, mental health, and medication side effects (some antidepressants and blood pressure medications reduce libido) can all contribute simultaneously. A doctor can help identify which factors are most relevant to you specifically, rather than assuming a single cause.

Does this mean something is wrong with my relationship?

Not necessarily, and this is worth stating plainly because it is a common and painful assumption. A hormonal decline in desire can happen within a loving, healthy, well-communicated relationship just as easily as within a strained one.

The mistake many couples make is assuming reduced desire reflects the relationship’s health. In many cases it reflects a measurable physiological shift that would occur regardless of the relationship. That said, open communication about what has changed matters regardless of the cause. It can prevent a hormonal issue from becoming a relational one through misunderstanding.

In summary

Related reading

The version of you that experienced desire automatically has not disappeared. You are working with a different hormonal picture now, and that picture has real, workable solutions.

Last reviewed: July 2026  ·  Review due: October 2026  ·  Not therapy. Not medical advice. For your own use and understanding only.  ·  mysophora.com